Skip to main content

Table 4 Analysis of the health effects of toner exposure without adjustment for confounders (models 1 and 2)

From: Effects of toner-handling work on respiratory function, chest X-ray findings, and biomarkers of inflammation, allergy, and oxidative stress: a 10-year prospective Japanese cohort study

Parameters (unit)

Difference in yearly change in each parameter between the toner-handling group and non-toner-handling group (model 1)

Difference in yearly change in each parameter between the toner-handling group and non-toner-handling group (model 2)

Estimate

95% CI

P-value

AIC

Estimate

95% CI

P-value

AIC

Respiratory function tests

 VC (l)

0.0009

−0.002

0.003

0.459

− 3786.6

− 0.003

− 0.005

0.0002

0.067

− 4375.4

 %VC (%)

0.004

− 0.05

0.06

0.892

74,963.3

−0.07

− 0.1

− 0.004

0.037

74,441.0

 FEV1 (l)

0.0001

−0.002

0.002

0.925

− 7999.7

−0.001

− 0.004

0.001

0.272

− 8462.7

 %FEV1 (%)

0.02

− 0.05

0.08

0.608

76,776.5

−0.02

− 0.09

0.05

0.568

76,306.5

 FEV1/FVC (%)

−0.003

− 0.04

0.03

0.866

60,893.8

−0.002

− 0.04

0.04

0.903

60,721.0

 %FEV1/FVC (%)

0.006

−0.04

0.05

0.808

65,957.3

0.008

−0.04

0.06

0.727

65,790.5

 V25 (l/s)

0.0005

−0.003

0.004

0.747

4573.4

0.0002

−0.004

0.004

0.921

4303.0

 %V25 (%)

−0.06

− 0.2

0.10

0.457

102,127.6

−0.02

− 0.20

0.15

0.784

101,834.2

Biomarkers

 CRP (mg/dl)

0.0007

−0.002

0.003

0.635

3626.3

0.0006

−0.002

0.003

0.658

3620.2

 IgE (IU/ml)

3.2

−1.6

7.9

0.190

177,623.3

4.6

−1.00

10.1

0.108

175,403.0

 8-OHdG/Creatinine (ng/mg)

−0.01

− 0.03

0.0009

0.065

45,402.9

−0.01

−0.03

0.003

0.115

45,352.5

  1. Dependent variables comprised the parameters of respiratory function tests and the values of biomarkers in both models 1 and 2. In model 1, we treated toner-handling work, the survey year, and the interaction between toner-handling work and survey year as fixed effects and treated only the individual differences at baseline as the random effect (random intercept model). In model 2, we treated certain individual differences during the observation period and the individual differences at baseline as random effects (random intercept and slope models)
  2. CI confidence interval, AIC Akaike’s Information Criterion, VC vital capacity, %VC percentage of VC to predicted VC value, FEV1 forced expiratory volume in 1 s, %FEV1 percentage of FEV1 to predicted FEV1 value, FEV1/FVC percentage of forced expiratory volume in 1 s, %FEV1/FVC percentage of FEV1/FVC to predicted FEV1/FVC value, V25 maximal expiratory flow at 25% forced VC, CRP C-reactive protein, IgE immunoglobulin E, 8-OHdG 8-hydroxy-2′-deoxyguanosine